Matcha Stress Randomized Trial: What the Evidence Says

Quick Answer

Matcha Stress Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public-health sources, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 narrative review, 1 preclinical study.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• It was once most popular in Japan; however, in recent years, its use in the food industry has increased significantly. [Sławińska Paulina (2026); evidence level 3]
• Numerous recipes featuring matcha can be found online, and many cafés now offer various flavored versions of this beverage. [Sławińska Paulina (2026); evidence level 3]
• Thus, any stress associated with handling or gavage was expected to be distributed similarly across groups. [Zorlu Özge (2026); evidence level 4]
• Supplementary Figure 1 post-hoc Body weight increased progressively in all groups throughout the study. [Zorlu Özge (2026); evidence level 4]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

For matcha stress randomized trial, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Sławińska Paulina (2026). Matcha as a Source of Bioactive Compounds: A Review of Health-Promoting Properties and Potential Applications. DOI: 10.3390/nu18101613. PMCID: PMC13209849. PMID: 42197072. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13209849/
• Zorlu Özge (2026). Oral whole-leaf matcha partially attenuates UV-induced dermoepidermal disruption and collagen phenotype alterations in a rat model of repeated photoaging. DOI: 10.3389/fmed.2026.1813454. PMCID: PMC13290547. PMID: 42359064. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13290547/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.